0000919574-18-008210.txt : 20181228
0000919574-18-008210.hdr.sgml : 20181228
20181228173023
ACCESSION NUMBER: 0000919574-18-008210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181226
FILED AS OF DATE: 20181228
DATE AS OF CHANGE: 20181228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CDK ASSOCIATES, L.L.C.
CENTRAL INDEX KEY: 0001576081
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 181258130
BUSINESS ADDRESS:
STREET 1: C/O CAXTON CORPORATION
STREET 2: 731 ALEXANDER ROAD, BUILDING #2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: C/O CAXTON CORPORATION
STREET 2: 731 ALEXANDER ROAD, BUILDING #2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morenstein Scott D
CENTRAL INDEX KEY: 0001576113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 181258131
MAIL ADDRESS:
STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP
STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAXTON CORP
CENTRAL INDEX KEY: 0001388551
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 181258132
BUSINESS ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kovner Bruce
CENTRAL INDEX KEY: 0001325713
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 181258133
MAIL ADDRESS:
STREET 1: C/O CAXTON ASSOCIATES
STREET 2: 500 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
ownership.xml
X0306
4
2018-12-26
0
0001183765
Molecular Templates, Inc.
MTEM
0001576081
CDK ASSOCIATES, L.L.C.
C/O CAXTON CORPORATION
731 ALEXANDER ROAD, BLDG. 2
PRINCETON
NJ
08540
1
0
0
0
0001576113
Morenstein Scott D
C/O CAXTON ALTERNATIVE MANAGEMENT LP
1330 SIXTH AVENUE, 20TH FLOOR
NEW YORK
NY
10019
1
0
0
0
0001388551
CAXTON CORP
731 ALEXANDER ROAD
BUILDING 2
PRINCETON
NJ
08540
1
0
0
0
0001325713
Kovner Bruce
C/O CAXTON CORPORATION
731 ALEXANDER ROAD, BLDG. 2
PRINCETON
NJ
08540
1
0
0
0
Common Stock
2018-12-26
4
P
0
25000
3.45
A
1584241
D
These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
CDK Associates, L.L.C., By: Caxton Corporation, its Manager,By: /s/ Heath Weisberg, General Counsel
2018-12-28
/s/ Scott D. Morenstein
2018-12-28
Caxton Corporation, By: /s/ Heath Weisberg, General Counsel
2018-12-28
Bruce Kovner, By: /s/ Heath Weisberg, Attorney-in-Fact
2018-12-28